# Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?

> **NCT02806440** · PHASE4 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 58 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Low dose naltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02806440
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2019-12-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806440, "Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02806440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*